Literature DB >> 7625804

Fluconazole penetration in cerebral parenchyma in humans at steady state.

F Thaler1, B Bernard, M Tod, C P Jedynak, O Petitjean, P Derome, P Loirat.   

Abstract

We studied fluconazole penetration in the brain in five patients who had a deep cerebral tumor whose removal required the excision of healthy brain tissue. Plasma and brain samples were simultaneously obtained after oral ingestion of 400 mg of fluconazole daily for 4 days (90% of steady state). Fluconazole penetration in healthy cerebral parenchyma was determined. Plasma and brain samples were assayed by high-pressure liquid chromatography. Concentrations in plasma and brain tissue were 13.5 +/- 5.5 micrograms/ml and 17.6 +/- 6.6 micrograms/g, respectively. The average ratio of concentrations in the brain and plasma (four patients) was 1.33 (range, 0.70 to 2.39). Despite the lack of data concerning the penetration of fluconazole in brain abscesses, these results should permit the use of a daily dose of 400 mg of fluconazole in prospective clinical studies that evaluate the effectiveness of this drug in the treatment of brain abscesses due to susceptible species of fungi.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625804      PMCID: PMC162699          DOI: 10.1128/AAC.39.5.1154

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans.

Authors:  M J Humphrey; S Jevons; M H Tarbit
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

Review 2.  Susceptibility testing of fungi: current status of the standardization process.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

3.  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.

Authors:  S L Chuck; M A Sande
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

4.  Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.

Authors:  J J Stern; B J Hartman; P Sharkey; V Rowland; K E Squires; H W Murray; J R Graybill
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

5.  Pharmacokinetics and tissue penetration of fluconazole in rabbits.

Authors:  T J Walsh; G Foulds; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

6.  Cryptococcal meningitis in patients with AIDS.

Authors:  W E Dismukes
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

7.  Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

Authors:  A Zuger; E Louie; R S Holzman; M S Simberkoff; J J Rahal
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

8.  Fluconazole in the treatment of persistent coccidioidomycosis.

Authors:  A Catanzaro; J Fierer; P J Friedman
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

9.  Fluconazole penetration into cerebrospinal fluid in humans.

Authors:  G Foulds; D R Brennan; C Wajszczuk; A Catanzaro; D C Garg; W Knopf; M Rinaldi; D J Weidler
Journal:  J Clin Pharmacol       Date:  1988-04       Impact factor: 3.126

10.  Cryptococcal intracerebral mass lesions: the role of computed tomography and nonsurgical management.

Authors:  N K Fujita; M Reynard; F L Sapico; L B Guze; J E Edwards
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

View more
  19 in total

1.  Human tissue distribution of voriconazole.

Authors:  Stefan Weiler; David Fiegl; Róisín MacFarland; Eva Stienecke; Rosa Bellmann-Weiler; Stefan Dunzendorfer; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 3.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

Review 4.  Beyond tissue concentrations: antifungal penetration at the site of infection.

Authors:  Yanan Zhao; Brendan Prideaux; Shane Baistrocchi; Donald C Sheppard; David S Perlin
Journal:  Med Mycol       Date:  2019-04-01       Impact factor: 4.076

5.  Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans.

Authors:  Robert A Larsen; Madeline Bauer; Ann M Thomas; Alejandro Sanchez; Diane Citron; Meri Rathbun; Thomas S Harrison
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Effects of immunomodulatory and organism-associated molecules on the permeability of an in vitro blood-brain barrier model to amphotericin B and fluconazole.

Authors:  Vasilios Pyrgos; Diane Mickiene; Tin Sein; Margaret Cotton; Andrea Fransesconi; Isaac Mizrahi; Martha Donoghue; Nikkida Bundrant; Su-Young Kim; Matthew Hardwick; Shmuel Shoham; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

7.  Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis.

Authors:  H Yang; Q Wang; W F Elmquist
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

8.  Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.

Authors:  K Chemlal; L Saint-Julien; V Joly; R Farinotti; N Seta; P Yeni; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

9.  Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.

Authors:  W Manosuthi; P Chetchotisakd; T L Nolen; D Wallace; S Sungkanuparph; T Anekthananon; K Supparatpinyo; P G Pappas; R A Larsen; S G Filler; D Andes
Journal:  HIV Med       Date:  2009-12-08       Impact factor: 3.180

10.  Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.

Authors:  Lucy Sasongko; Kenneth M Williams; Richard O Day; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.